5-Year Follow-Up Data For CPX-351 in AML

Video

Alexandra S. Wolff, PharmD, BCOP, explores the 5-year follow-up data from the phase 3 trial of CPX-351 in AML.

Related Videos
Image Credit: © Anastasiia - stock.adobe.com
hematological cancer/Image Credit: © nikola-master - stock.adobe.com
lymphoma, OPC, ASCO 2024, hodgkin lymphoma
MP Studio - stock.adobe.com
Image credit: David A Litman | stock.adobe.com
Credit: AkuAku - stock.adobe.com
Image credit: Halfpoint | stock.adobe.com
Credit: AkuAku - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.